Anti-Interleukin-6 Receptor Antibody Treatment in Inflammatory Autoimmune Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1876-1038|1|3|193-200

ISSN： 1574-8871

Source： Reviews on Recent Clinical Trials, Vol.1, Iss.3, 2006-09, pp. : 193-200

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tocilizumab: A novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases

By Alten Rieke   Maleitzke Tazio  

Annals of Medicine, Vol. 45, Iss. 4, 2013-06 ,pp. : 357-363

Informa Healthcare

Access to resources Recommend Favorite

Successful Treatment of Autoimmune Hemolytic Anemia Associated with Multicentric Castleman Disease by Anti-Interleukin-6 Receptor Antibody (Tocilizumab) Therapy

By  

Acta Haematologica, Vol. 126, Iss. 3, 2011-07 ,pp. : 147-150

Karger

Access to resources Recommend Favorite

The blockade of interleukin-6 receptor as a therapeutic strategy for chronic inflammatory diseases

By Hoshino-Yoshio Naoko   Watanabe Dai   Adachi Yasuo   Nishimoto Norihiro  

Therapy, Vol. 1, Iss. 2, 2004-11 ,pp. : 267-275

Future Medicine

Access to resources Recommend Favorite

Evaluation of disease‐mediated therapeutic protein–drug interactions between an anti–interleukin‐6 monoclonal antibody (sirukumab) and cytochrome P450 activities in a phase 1 study in patients with rheumatoid arthritis using a cocktail approach

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 12, 2015-12 ,pp. : 1386-1394

John Wiley & Sons Inc

Access to resources Recommend Favorite

Anti‐Interleukin Therapy in Asthma

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 1, 2015-01 ,pp. : 55-65

John Wiley & Sons Inc

Access to resources Recommend Favorite